Works matching IS 11732563 AND DT 2024 AND VI 44 AND IP 5


Results: 7
    1
    2

    PB006: A Natalizumab Biosimilar.

    Published in:
    Clinical Drug Investigation, 2024, v. 44, n. 5, p. 367, doi. 10.1007/s40261-024-01360-4
    By:
    • Shirley, Matt
    Publication type:
    Article
    3

    Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label, Single-Center, Multiple-Dosage, Self-Controlled, Phase I Trial.

    Published in:
    Clinical Drug Investigation, 2024, v. 44, n. 5, p. 343, doi. 10.1007/s40261-024-01359-x
    By:
    • Du, Yujing;
    • Yu, Lixiu;
    • Deng, Bin;
    • Li, Qinying;
    • Hu, Junrui;
    • Li, Linjie;
    • Xu, Yusen;
    • Song, Liangwei;
    • Xie, Fang;
    • Wang, Yinghui;
    • Chen, Yuhao;
    • Liu, Chengxin;
    • Zhai, Xuejia;
    • Lu, Yongning
    Publication type:
    Article
    4
    5
    6
    7